Biofrontera (BFRI) Cash & Equivalents (2020 - 2026)
Biofrontera (BFRI) reported Cash & Equivalents of $4.7 million for Q2 2026, down 35.1% from $7.24 million a year earlier.
Powered by 
Analysis
Biofrontera (BFRI) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Biofrontera posted Cash & Equivalents of $6.4 million, up 8.4% from FY2024.
- Cash & Equivalents has a five-year compound annual growth rate of -4.6% (FY2020 to FY2025).
- By year, Cash & Equivalents came in at $5.91 million in FY2024 (+339.7%), $1.34 million in FY2023 (-92.2%), $17.21 million in FY2022 (-29.9%) and $24.55 million in FY2021 (+203.0%).
- Five-year quarterly Cash & Equivalents spans a low of $1.3 million in Q1 2023 and a high of $31.91 million in Q2 2022.
- Year over year, Cash & Equivalents gained in four of the last seven quarters, with growth averaging 46.7%.
- The high point for year-over-year Cash & Equivalents in five years was Q4 2024 (growth of 339.7%); the low point was Q1 2023 (a decline of 94.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Biofrontera | 14.77 Mn | -7.02 Mn | 9.59 Mn | 4.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.70 Mn |
| Dec 31, 2025 | 6.40 Mn |
| Sep 30, 2025 | 3.42 Mn |
| Jun 30, 2025 | 7.24 Mn |
| Mar 31, 2025 | 1.80 Mn |
| Dec 31, 2024 | 5.91 Mn |
| Sep 30, 2024 | 2.90 Mn |
| Jun 30, 2024 | 4.40 Mn |
| Mar 31, 2024 | 3.82 Mn |
| Dec 31, 2023 | 1.34 Mn |
| Sep 30, 2023 | 3.42 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 17.21 Mn |
| Sep 30, 2022 | 27.52 Mn |
| Jun 30, 2022 | 31.91 Mn |
| Mar 31, 2022 | 22.43 Mn |
| Dec 31, 2021 | 24.55 Mn |
| Sep 30, 2021 | 1.72 Mn |
| Dec 31, 2020 | 8.10 Mn |
API Access
Biofrontera Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BFRI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "BFRI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=BFRI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();